BBNX (Beta Bionics) Other Operating Expense: $-0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BBNX Beta Bionics Inc BBNX
10 GF Score
Price $16.40
! 3 Warning Signs
View Full Analysis

What is Beta Bionics Other Operating Expense?

Beta Bionics BBNX +3.14% 10 Other Operating Expense is $-0.0 Mil as of Jun. 2026. GuruFocus rates BBNX with a GF Score™ of 10/100. The stock has 3 warning signs investors should review.

Beta Bionics's Other Operating Expense for the three months ended in Jun. 2026 was $0.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.0 Mil.

Beta Bionics's quarterly Other Operating Expense stayed the same from Dec. 2025 ($-0.0 Mil) to Mar. 2026 ($-0.0 Mil) but then increased from Mar. 2026 ($-0.0 Mil) to Jun. 2026 ($0.0 Mil).

Beta Bionics's annual Other Operating Expense stayed the same from Dec. 2023 ($0.0 Mil) to Dec. 2024 ($0.0 Mil) but then declined from Dec. 2024 ($0.0 Mil) to Dec. 2025 ($-0.0 Mil).

Beta Bionics Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Beta Bionics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beta Bionics Other Operating Expense Chart

Beta Bionics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Operating Expense
0.00 0.00 0.00 -0.00

Beta Bionics Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.00 -0.00 0.00
BBNX
10GF Score
Beta Bionics Inc BBNX
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beta Bionics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $-0.0 Mil mean?
Beta Bionics (BBNX) has a Other Operating Expense of $-0.0 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Beta Bionics and its competitors.
Is Beta Bionics' Other Operating Expense too high?
Beta Bionics' current Other Operating Expense is $-0.0 Mil. Overall, Beta Bionics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Beta Bionics' Other Operating Expense compare to SSII and SIBN?
Beta Bionics' Other Operating Expense of $-0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Beta Bionics and its competitors. Beta Bionics's current Other Operating Expense is $-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beta Bionics stock overvalued right now?
Beta Bionics (BBNX) has a current Other Operating Expense of $-0.0 Mil. The current Other Operating Expense is $-0.0 Mil. Beta Bionics' overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Beta Bionics (BBNX), the current Other Operating Expense is $-0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beta Bionics Business Description

Address 11 Hughes, Irvine, CA, USA, 92618
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
10GF Score

Get the complete analysis for BBNX

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.40
Price